Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cardio Diagnostics Holdings ( (CDIO) ) just unveiled an update.
On October 15, 2025, Cardio Diagnostics Holdings, Inc. held its annual meeting of stockholders, where approximately 52.6% of eligible shares were represented. During the meeting, stockholders elected seven directors, approved the issuance of additional shares in non-public transactions, and ratified the appointment of Prager Metis CPA’s LLC as the independent registered public accounting firm for the fiscal year ending December 31, 2025. These decisions are expected to influence the company’s strategic direction and financial operations.
More about Cardio Diagnostics Holdings
Cardio Diagnostics Holdings, Inc. is a company operating in the healthcare industry, focusing on providing diagnostic solutions. The company is involved in the development and commercialization of products that utilize advanced technology for cardiovascular health assessment.
Average Trading Volume: 35,378
Technical Sentiment Signal: Sell
Current Market Cap: $7.82M
For a thorough assessment of CDIO stock, go to TipRanks’ Stock Analysis page.